Literature DB >> 19373223

Prospective study of BMI and the risk of pulmonary embolism in women.

Christopher Kabrhel1, Raphaëlle Varraso, Samuel Z Goldhaber, Eric B Rimm, Carlos A Camargo.   

Abstract

Pulmonary embolism (PE) is common and associated with significant morbidity and mortality. An association between obesity and PE has been suggested, but the nature of the association has not been well defined. We performed a prospective cohort study of 87,226 women in the Nurses' Health Study (1984-2002) to define the association between BMI and the risk of incident PE. Primary exposure was BMI (<22.5, 22.5-24.9, 25.0-27.4, 27.5-29.9, 30.0-34.9, and >or=35.0 kg/m(2)). Primary outcome was idiopathic PE (medical record confirmed cases of PE not associated with prior surgery, trauma, or malignancy). Secondary analysis of nonidiopathic PE was also performed. Multivariable Cox proportional hazards models were controlled for age, physical activity, caloric intake, smoking, pack-years, race, spouse's educational attainment, parity, menopause, nonaspirin nonsteroidal anti-inflammatory drugs, warfarin, multivitamin supplements, hypertension, coronary heart disease, and rheumatological disease. There were 157 incident idiopathic PE and 338 nonidiopathic PE. There was a strong positive association between BMI, the risk of idiopathic PE (relative risk (RR) = 1.08 (95% confidence interval (CI), 1.06-1.10) per 1 kg/m(2) increase in BMI, P < 0.001) and nonidiopathic PE (RR = 1.08 (95% CI, 1.07-1.10), P < 0.001). The association was linear, and apparent even with modest increases in BMI (22.5-25 kg/m(2)). The risk increased nearly sixfold among subjects with BMI >or=35 kg/m(2), and was present in multiple subgroups. Increasing BMI has a strong, linear association with the development of PE in women. Clinicians should consider BMI when assessing the risk of PE in their patients.

Entities:  

Mesh:

Year:  2009        PMID: 19373223      PMCID: PMC3769947          DOI: 10.1038/oby.2009.92

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  31 in total

1.  Pulmonary embolism as a cause of cardiac arrest: presentation and outcome.

Authors:  I Kürkciyan; G Meron; F Sterz; K Janata; H Domanovits; M Holzer; A Berzlanovich; H C Bankl; A N Laggner
Journal:  Arch Intern Med       Date:  2000-05-22

2.  Risk factors for pulmonary embolism. The Framingham Study.

Authors:  S Z Goldhaber; D D Savage; R J Garrison; W P Castelli; W B Kannel; P M McNamara; G Gherardi; M Feinleib
Journal:  Am J Med       Date:  1983-06       Impact factor: 4.965

3.  Cigarette smoking, relative weight, and menopause.

Authors:  W Willett; M J Stampfer; C Bain; R Lipnick; F E Speizer; B Rosner; D Cramer; C H Hennekens
Journal:  Am J Epidemiol       Date:  1983-06       Impact factor: 4.897

4.  The coming epidemic of obesity in elderly Americans.

Authors:  David E Arterburn; Paul K Crane; Sean D Sullivan
Journal:  J Am Geriatr Soc       Date:  2004-11       Impact factor: 5.562

5.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

Authors:  Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Joseph F Polak; Aaron R Folsom
Journal:  Arch Intern Med       Date:  2002-05-27

6.  Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Raffaele Pesavento; Mauro Silingardi; Renzo Poggio; Maria Rita Taliani; Walter Ageno
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

7.  Venous thromboembolism epidemiology: implications for prevention and management.

Authors:  John A Heit
Journal:  Semin Thromb Hemost       Date:  2002-06       Impact factor: 4.180

8.  Prevalence and correlates of overweight and obesity among older adults: findings from the Canadian National Population Health Survey.

Authors:  Mark S Kaplan; Nathalie Huguet; Jason T Newsom; Bentson H McFarland; Joan Lindsay
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-11       Impact factor: 6.053

9.  Estrogen plus progestin and risk of venous thrombosis.

Authors:  Mary Cushman; Lewis H Kuller; Ross Prentice; Rebecca J Rodabough; Bruce M Psaty; Randall S Stafford; Steven Sidney; Frits R Rosendaal
Journal:  JAMA       Date:  2004-10-06       Impact factor: 56.272

10.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Authors:  Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

View more
  33 in total

1.  Reduction in physical function in women after venous thromboembolism.

Authors:  K A Hagan; L B Harrington; J Kim; O Zeleznik; E B Rimm; F Grodstein; C Kabrhel
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

2.  Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism.

Authors:  Christopher Kabrhel; D Mark Courtney; Carlos A Camargo; Michael C Plewa; Kristen E Nordenholz; Christopher L Moore; Peter B Richman; Howard A Smithline; Daren M Beam; Jeffrey A Kline
Journal:  Acad Emerg Med       Date:  2010-06       Impact factor: 3.451

3.  Predictors of Overtesting in Pulmonary Embolism Diagnosis.

Authors:  Safiya Richardson; Eugene Lucas; Stuart L Cohen; Meng Zhang; Guang Qiu; Sundas Khan; Thomas McGinn
Journal:  Acad Radiol       Date:  2019-05-31       Impact factor: 3.173

4.  Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology.

Authors:  Mary Cushman; Ellen S O'Meara; Susan R Heckbert; Neil A Zakai; Wayne Rosamond; Aaron R Folsom
Journal:  Thromb Res       Date:  2016-06-15       Impact factor: 3.944

5.  Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk.

Authors:  Jihye Kim; Peter Kraft; Kaitlin A Hagan; Laura B Harrington; Sara Lindstroem; Christopher Kabrhel
Journal:  Genet Epidemiol       Date:  2018-03-08       Impact factor: 2.135

6.  Prospective study of diet and venous thromboembolism in US women and men.

Authors:  Raphaëlle Varraso; Christopher Kabrhel; Samuel Z Goldhaber; Eric B Rimm; Carlos A Camargo
Journal:  Am J Epidemiol       Date:  2011-12-15       Impact factor: 4.897

7.  The association of obesity with hearing thresholds in women aged 18-40 years.

Authors:  Rıfkı Üçler; Mahfuz Turan; Fatih Garça; İsmail Acar; Murat Atmaca; Hakan Çankaya
Journal:  Endocrine       Date:  2015-10-01       Impact factor: 3.633

8.  Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study.

Authors:  Sara Lindström; Marine Germain; Marta Crous-Bou; Erin N Smith; Pierre-Emmanuel Morange; Astrid van Hylckama Vlieg; Hugoline G de Haan; Daniel Chasman; Paul Ridker; Jennifer Brody; Mariza de Andrade; John A Heit; Weihong Tang; Immaculata DeVivo; Francine Grodstein; Nicholas L Smith; David Tregouet; Christopher Kabrhel
Journal:  Hum Genet       Date:  2017-05-20       Impact factor: 4.132

9.  Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.

Authors:  Marta Crous-Bou; Immaculata De Vivo; Carlos A Camargo; Raphaëlle Varraso; Francine Grodstein; Majken K Jensen; Peter Kraft; Samuel Z Goldhaber; Sara Lindström; Christopher Kabrhel
Journal:  Thromb Haemost       Date:  2016-06-16       Impact factor: 5.249

10.  Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients.

Authors:  Jeffrey Beall; Ashley Woodruff; Carolyn Hempel; Margaret Wovkulich; Kimberly Zammit
Journal:  Hosp Pharm       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.